Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 500,000 new cases each year (WHO Report 2006). Most of these cases (90%) occur in the developing world where it is the second most common malignancy in women after breast cancer (WHO Report 2006). By contrast, in the United States (U.S.) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health care services. In the U.S., an individual woman’s lifetime risk of developing cervical cancer is estimated to be 1 in 142 (Ries et al. 2007). In 2008, it is estimated that there were approximately 11,070 new cases of cervical cancer, and 3,870 deaths in the U.S. (Jemal et al. 2008).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Garcia, F., Nuno, T., Mitchell, A.L. (2008). Cervical Cancer Prevention. In: Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68986-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-540-68986-7_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-68985-0
Online ISBN: 978-3-540-68986-7
eBook Packages: MedicineMedicine (R0)